|
IL36670A
(en)
|
1971-04-21 |
1974-09-10 |
Sela M |
Therapeutic basic copolymers of amino acids
|
|
US3723506A
(en)
|
1971-08-11 |
1973-03-27 |
Univ Sherbrooke |
Oxidation of sugars
|
|
DE2917104A1
(de)
|
1979-04-27 |
1980-11-06 |
Hoechst Ag |
Verfahren zur viskositaetserniedrigung von celluloseethern durch ozon und seine verwendung
|
|
JPS56128721A
(en)
|
1980-03-12 |
1981-10-08 |
Eisai Co Ltd |
Antiallergic agent
|
|
US4356170A
(en)
|
1981-05-27 |
1982-10-26 |
Canadian Patents & Development Ltd. |
Immunogenic polysaccharide-protein conjugates
|
|
JPS60501259A
(ja)
|
1983-05-06 |
1985-08-08 |
ウイスコンシン・アルムニ・リサ−チ・フアンデ−シヨン |
免疫刺激活性をもつ単糖類化合物
|
|
JPS618945A
(ja)
|
1984-06-25 |
1986-01-16 |
Nec Corp |
半導体集積回路装置
|
|
SE456346B
(sv)
|
1984-07-23 |
1988-09-26 |
Pharmacia Ab |
Gel for att forhindra adhesion mellan kroppsvevnader och sett for dess framstellning
|
|
US4619995A
(en)
|
1984-12-24 |
1986-10-28 |
Nova Chem Limited |
N,O-carboxymethyl chitosan and preparative method therefor
|
|
DE3650242T2
(de)
|
1985-07-12 |
1995-06-14 |
Univ New York |
Mit dem plasmodium-vivax-circumsporozoit-protein übereinstimmendes immunogenes peptidantigen.
|
|
US4684727A
(en)
|
1985-07-29 |
1987-08-04 |
Schering Corporation |
Zwitterionic 1,8-naphthyridine and pyrazino[2,3-b]pyridine containing compounds useful as anti-allergic, anti-inflammatory and cycloprotective agents
|
|
ATE107697T1
(de)
|
1986-03-26 |
1994-07-15 |
Genexpress Aps |
Biologische eindämmung.
|
|
US4775626A
(en)
|
1986-05-23 |
1988-10-04 |
Syntex (U.S.A.) Inc. |
Method and compositions for protecting anerobic microorganisms
|
|
US4819617A
(en)
|
1986-09-04 |
1989-04-11 |
University Of Florida |
Viscoelastic material for ophthalmic surgery
|
|
US5514581A
(en)
|
1986-11-04 |
1996-05-07 |
Protein Polymer Technologies, Inc. |
Functional recombinantly prepared synthetic protein polymer
|
|
DE3704389A1
(de)
|
1987-02-12 |
1988-08-25 |
Blutspendedienst Dt Rote Kreuz |
Verfahren zur herstellung von lymphokinen durch induktion lymphoider zellen
|
|
US4835252A
(en)
|
1987-02-26 |
1989-05-30 |
The Salk Institute Biotechnology/Industrial Associates, Inc. |
Vasoactive intestinal peptide analogs
|
|
US5215896A
(en)
|
1987-03-20 |
1993-06-01 |
Creative Biomolecules, Inc. |
Leader sequences for the production of recombinant proteins
|
|
US6174999B1
(en)
|
1987-09-18 |
2001-01-16 |
Genzyme Corporation |
Water insoluble derivatives of polyanionic polysaccharides
|
|
US4937270A
(en)
|
1987-09-18 |
1990-06-26 |
Genzyme Corporation |
Water insoluble derivatives of hyaluronic acid
|
|
US5140016A
(en)
|
1988-05-31 |
1992-08-18 |
University Of Florida |
Method and composition for preventing surgical adhesions using a dilute solution of polymer
|
|
US5126141A
(en)
|
1988-11-16 |
1992-06-30 |
Mediventures Incorporated |
Composition and method for post-surgical adhesion reduction with thermo-irreversible gels of polyoxyalkylene polymers and ionic polysaccharides
|
|
DE3840044A1
(de)
|
1988-11-27 |
1990-06-07 |
Behringwerke Ag |
Glykosphingolipide mit kopplungsfaehiger gruppe im sphingoidanteil, ihre herstellung und verwendung
|
|
US5196510A
(en)
|
1988-12-29 |
1993-03-23 |
Cytogen Corporation |
Molecular recognition units
|
|
FI895708A7
(fi)
|
1989-02-10 |
1990-08-11 |
Alko Ab Oy |
Vesiliukoinen hajoamistuote
|
|
US4952524A
(en)
|
1989-05-05 |
1990-08-28 |
At&T Bell Laboratories |
Semiconductor device manufacture including trench formation
|
|
US5158939A
(en)
|
1989-07-21 |
1992-10-27 |
Wisconsin Alumni Research Foundation |
Method of stimulating the immune systems of animals and compositions useful therefor
|
|
ATE121947T1
(de)
|
1989-12-14 |
1995-05-15 |
Ca Nat Research Council |
Verbessertes meningokokkale polysaccharidkonjugatvakzin.
|
|
US5268454A
(en)
|
1991-02-08 |
1993-12-07 |
La Jolla Pharmaceutical Company |
Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
|
|
US5130417A
(en)
|
1990-04-30 |
1992-07-14 |
Washington University |
Entamoeba histolytical immunogenic protein and cdna clone
|
|
US5331573A
(en)
|
1990-12-14 |
1994-07-19 |
Balaji Vitukudi N |
Method of design of compounds that mimic conformational features of selected peptides
|
|
KR940006696B1
(ko)
|
1991-01-16 |
1994-07-25 |
금성일렉트론 주식회사 |
반도체 소자의 격리막 형성방법
|
|
CA2059693C
(en)
|
1991-01-28 |
2003-08-19 |
Peter J. Kniskern |
Polysaccharide antigens from streptococcus pneumoniae
|
|
GB2254083A
(en)
|
1991-03-28 |
1992-09-30 |
Italfarmaco Spa |
Anticoagulants from e.coli saccharide
|
|
GR920100122A
(el)
|
1991-04-05 |
1993-03-16 |
Ethicon Inc |
Πολυσακχαρίτες οι οποίοι περιέχουν καρβοξύλιο με σταυροειδείς δεσμούς δια την πρόληψιν της προσφύσεως.
|
|
US5705178A
(en)
|
1991-05-31 |
1998-01-06 |
Gliatech, Inc. |
Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
|
|
US5605938A
(en)
|
1991-05-31 |
1997-02-25 |
Gliatech, Inc. |
Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
|
|
US5936076A
(en)
|
1991-08-29 |
1999-08-10 |
Kirin Beer Kabushiki Kaisha |
αgalactosylceramide derivatives
|
|
US20050181021A1
(en)
|
1992-02-14 |
2005-08-18 |
Robert Lamb |
Vitamin E phosphate/phosphatidycholine liposomes to protect from or ameliorate cell damage
|
|
US5350941A
(en)
|
1992-09-23 |
1994-09-27 |
Texas Instruments Incorporated |
Trench isolation structure having a trench formed in a LOCOS structure and a channel stop region on the sidewalls of the trench
|
|
IL107103A
(en)
|
1992-09-24 |
2001-03-19 |
Brigham & Womens Hospital |
Multivalent vaccine based on conjugated molecule comprising a capsular polysaccharide linked to a protein and a method for the preparation thereof
|
|
US5433794A
(en)
|
1992-12-10 |
1995-07-18 |
Micron Technology, Inc. |
Spacers used to form isolation trenches with improved corners
|
|
US5728385A
(en)
|
1993-08-12 |
1998-03-17 |
Classen Immunotherapies, Inc. |
Method and composition for an early vaccine to protect against both common infectious diseases and chronic immune mediated disorders or their sequelae
|
|
JPH09505603A
(ja)
|
1993-11-26 |
1997-06-03 |
ヘンドリー，ローレンス，ビー． |
レセプター−リガンド−ｄｎａ相互作用に係わる薬剤の設計
|
|
IL113812A
(en)
|
1994-05-24 |
2000-06-29 |
Yeda Res & Dev |
Copolymer-1 pharmaceutical compositions containing it and its use
|
|
JPH07326664A
(ja)
|
1994-05-31 |
1995-12-12 |
Fuji Electric Co Ltd |
ウエハの誘電体分離溝の充填方法
|
|
US5565204A
(en)
|
1994-08-24 |
1996-10-15 |
American Cyanamid Company |
Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
|
|
US5679654A
(en)
|
1994-09-02 |
1997-10-21 |
Brigham & Women's Hospital, Inc. |
Capsular polysaccharide immunomodulator
|
|
US5700787A
(en)
|
1994-09-02 |
1997-12-23 |
Brigham & Women's Hospital, Inc. |
Capsular polysaccharide immunomodulator
|
|
NZ296748A
(en)
|
1994-11-02 |
1999-11-29 |
Univ New York State Res Found |
Peripheral nervous system specific sodium channel proteins, DNA coding therefor, compositions and methods
|
|
US5858964A
(en)
|
1995-04-14 |
1999-01-12 |
Yeda Research And Development Co. Ltd. |
Pharmaceutical compositions comprising synthetic peptide copolymer for prevention of GVHD
|
|
US5679658A
(en)
|
1995-05-08 |
1997-10-21 |
Chitogenics, Inc. |
N,O-carbonxymethylchitosan for prevention of surgical adhesions
|
|
US5851808A
(en)
|
1997-02-28 |
1998-12-22 |
Baylor College Of Medicine |
Rapid subcloning using site-specific recombination
|
|
JP2001519817A
(ja)
|
1997-03-26 |
2001-10-23 |
ブリガム アンド ウイメンズ ホスピタル |
糖断片生成法
|
|
ATE229038T1
(de)
|
1997-04-04 |
2002-12-15 |
Fidia Advanced Biopolymers Srl |
N-sulfatierte hyaluronsäureverbindungen, ihre derivate und verfahren zu ihrer herstellung
|
|
US6749831B1
(en)
|
1997-05-16 |
2004-06-15 |
Medical Defense Technology, Llc |
Vaccine against lipopolysaccharide core
|
|
US5929049A
(en)
|
1997-08-08 |
1999-07-27 |
Dade Behring Marburg Gmbh |
Polysaccharide conjugates of biomolecules
|
|
EP0908179A1
(en)
|
1997-08-23 |
1999-04-14 |
Werner Bollag |
Treatment of cell-mediated immune diseases
|
|
US6015787A
(en)
|
1997-11-04 |
2000-01-18 |
New England Medical Center Hospitals, Inc. |
Cell-permeable protein inhibitors of calpain
|
|
AU3066599A
(en)
|
1998-03-03 |
1999-10-18 |
University Of Southern California |
Use of cytokines and mitogens to inhibit graft versus host disease
|
|
AU752942B2
(en)
|
1998-04-13 |
2002-10-03 |
Massachusetts Institute Of Technology |
Comb copolymers for regulating cell-surface interactions
|
|
ITPD980169A1
(it)
|
1998-07-06 |
2000-01-06 |
Fidia Advanced Biopolymers Srl |
Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione.
|
|
CA2366895A1
(en)
|
1999-04-02 |
2000-10-12 |
Brigham And Women's Hospital, Inc. |
Immunomodulating polymers
|
|
US7083777B1
(en)
|
1999-04-02 |
2006-08-01 |
The Brigham And Women's Hospital, Inc. |
Immunomodulating polymers
|
|
EP1459757A1
(en)
|
1999-04-02 |
2004-09-22 |
The Brigham And Women's Hospital, Inc. |
Immunomodulating polymers
|
|
JP2001055335A
(ja)
|
1999-08-18 |
2001-02-27 |
Toshio Sato |
アレルギー性皮膚疾患治療剤
|
|
US6995237B1
(en)
|
1999-10-27 |
2006-02-07 |
Cel-Sci Corporation |
Preparation and composition of peptides useful for treatment of autoimmune and transplant related graft versus host conditions
|
|
US6358939B1
(en)
|
1999-12-21 |
2002-03-19 |
Northern Lights Pharmaceuticals, Llc |
Use of biologically active vitamin D compounds for the prevention and treatment of inflammatory bowel disease
|
|
CA2416120A1
(en)
|
2000-07-17 |
2002-01-24 |
Svend Laulund |
Methods and formulations with probiotic microorganisms and medicaments
|
|
AUPQ899700A0
(en)
|
2000-07-25 |
2000-08-17 |
Borody, Thomas Julius |
Probiotic recolonisation therapy
|
|
US6670146B2
(en)
|
2000-10-04 |
2003-12-30 |
Schering Corporation |
Regulatory T cells; methods
|
|
SV2003000753A
(es)
|
2000-12-05 |
2003-06-16 |
Brigham & Womens Hospital |
Uso de polisacaridos zwitterionicos para la especifica modulacion del progreso inmunologico
|
|
CN1496266A
(zh)
|
2001-01-12 |
2004-05-12 |
������ҩ��ʽ���� |
抗变态反应剂
|
|
EP1361863A2
(en)
|
2001-02-13 |
2003-11-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Carotenoid-loaded liposomes
|
|
ATE489968T1
(de)
|
2001-03-09 |
2010-12-15 |
Id Biomedical Corp Quebec |
Proteosom-liposaccharid-vakzine-adjuvans
|
|
US20050101012A1
(en)
|
2001-03-12 |
2005-05-12 |
Gerold Schuler |
CD4+CD25+ regulatory T cells from human blood
|
|
EP1409009A1
(en)
*
|
2001-06-15 |
2004-04-21 |
Nordic Vaccine Technology A/S |
Therapeutical vaccination
|
|
EP1308167A1
(de)
|
2001-11-06 |
2003-05-07 |
Pickl, Winfried, Ao. Univ. Prof. Dr. |
Antigenpräsentierende Vesikel
|
|
GB0130123D0
(en)
|
2001-12-17 |
2002-02-06 |
Microbiological Res Agency |
Outer membrane vesicle vaccine and its preparation
|
|
US20030147865A1
(en)
|
2002-02-07 |
2003-08-07 |
Benoit Salomon |
Cell therapy using immunoregulatory T-cells
|
|
ES2320334T3
(es)
*
|
2002-02-22 |
2009-05-21 |
National Research Council Of Canada |
Uso de analogos de acidos grasos para el tratamiento y/o prevencion de enfermedades proliferativas de la piel.
|
|
US7629313B2
(en)
|
2002-03-08 |
2009-12-08 |
Eli Lilly And Company |
Immunomodulatory polymeric antigens for treating inflammatory pathologies
|
|
CA2479246C
(en)
|
2002-03-13 |
2017-05-09 |
Laurie E. Comstock |
Method for overexpression of zwitterionic polysaccharides
|
|
US7829289B2
(en)
|
2002-05-14 |
2010-11-09 |
Institut National De La Sante Et De Recherche Medicale |
T cell subpopulation regulating gut immunity
|
|
GB0213622D0
(en)
|
2002-06-13 |
2002-07-24 |
Glaxosmithkline Biolog Sa |
Vaccine Corporation
|
|
DK1531832T3
(da)
|
2002-06-28 |
2009-07-27 |
Glykos Finland Oy |
Terapeutiske sammensætninger til anvendelse ved profylakse eller behandling af diarré
|
|
US20060160153A1
(en)
|
2002-12-03 |
2006-07-20 |
Jean-Pierre Abastado |
Method to measure a t cell response and its uses to qualify antigen-presenting cells
|
|
US20040219160A1
(en)
|
2003-03-31 |
2004-11-04 |
The Brigham And Women's Hospital, Inc. |
Zwitterionic immunomodulators for the treatment of asthma and allergy
|
|
NZ543467A
(en)
|
2003-04-10 |
2008-07-31 |
Novartis Vaccines & Diagnostic |
The severe acute respiratory syndrome coronavirus
|
|
US20050048587A1
(en)
|
2003-07-17 |
2005-03-03 |
Tolerrx, Inc. |
Methods for identifying tolerance modulatory compounds and uses therefor
|
|
US6846807B1
(en)
|
2003-07-25 |
2005-01-25 |
Board Of Regents, The University Of Texas System |
Colorectal neoplasia prophylaxis
|
|
JP2007518394A
(ja)
|
2003-08-14 |
2007-07-12 |
ザ バイオ バランス コーポレイション |
細菌菌株、該細菌菌株を含む組成物、およびそのプロバイオティクス使用
|
|
DE10353593A1
(de)
|
2003-11-17 |
2005-06-23 |
Klinikum der Universität München Großhadern-Innenstadt |
Leptinantagonist und Verfahren zur quantitativen Messung von Leptin
|
|
CA2549001A1
(en)
|
2003-12-10 |
2005-06-30 |
Activbiotics, Inc. |
Rifamycin analogs and uses thereof
|
|
WO2006060117A2
(en)
|
2004-11-02 |
2006-06-08 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for inhibition of nkt cells
|
|
US8426146B2
(en)
|
2005-06-03 |
2013-04-23 |
University of Pittsburgh—of the Commonwealth System of Higher Education |
Multiparameteric method for assessing immune system status
|
|
AU2006297896B2
(en)
|
2005-10-06 |
2011-12-08 |
Probi Ab |
Use of lactobacillus for treatment of autoimmune diseases
|
|
AU2006335256B2
(en)
|
2005-11-22 |
2012-10-18 |
Novartis Vaccines And Diagnostics, Inc. |
Norovirus and sapovirus antigens
|
|
US8206726B2
(en)
|
2006-02-06 |
2012-06-26 |
The Brigham And Women's Hospital, Inc. |
Zwitterionic polysaccharides for promotion of immune system maturation and health
|
|
CN100366737C
(zh)
|
2006-03-01 |
2008-02-06 |
哈尔滨美华生物技术股份有限公司 |
固定化乳糖酶生产方法
|
|
US8802419B2
(en)
|
2006-03-02 |
2014-08-12 |
University Of Massachusetts |
Modified pathogens for use as vaccines
|
|
WO2007136719A2
(en)
|
2006-05-18 |
2007-11-29 |
Biobalance Llc |
Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof
|
|
EP2032695B1
(en)
|
2006-05-31 |
2018-08-15 |
The Regents of The University of California |
Cd127 expression inversely correlates with foxp3 and suppressive function of cd4+ tregs
|
|
PT103495B
(pt)
|
2006-06-05 |
2017-05-12 |
Faculdade De Farmácia Da Univ De Lisboa |
Pró-fármacos de ácidos orgânicos e composições farmacêuticas contendo os referidos pró-fármacos
|
|
KR101378872B1
(ko)
|
2006-09-26 |
2014-04-11 |
인펙셔스 디지즈 리서치 인스티튜트 (아이디알아이) |
합성 애주번트를 함유하는 백신 조성물
|
|
HUE030386T2
(en)
|
2007-01-31 |
2017-05-29 |
Yeda Res & Dev |
Redirected, genetically-engineered t regulatory cells and their use in suppression of autoimmune and inflammatory disease
|
|
TW200904340A
(en)
|
2007-05-11 |
2009-02-01 |
Mannatech Inc |
Processing of natural polysaccharides by selected non-pathogenic microorganisms and methods of making and using the same
|
|
US8092998B2
(en)
|
2007-05-31 |
2012-01-10 |
Abbott Laboratories |
Biomarkers predictive of the responsiveness to TNFα inhibitors in autoimmune disorders
|
|
US20100221755A1
(en)
|
2007-06-15 |
2010-09-02 |
University Of Rochester |
Use of antibody secreting cell elispot to assess antibody responses following antigen exposure
|
|
WO2009035528A2
(en)
*
|
2007-09-07 |
2009-03-19 |
University Of Georgia Research Foundation, Inc. |
Synthetic lipid a derivative
|
|
US20110002965A1
(en)
|
2007-11-09 |
2011-01-06 |
Round June L |
Immunomodulating compounds and related compositions and methods
|
|
EP2217250A4
(en)
|
2007-11-09 |
2011-01-05 |
California Inst Of Techn |
IMMUNOMODULATING COMPOUNDS AND RELEVANT COMPOSITIONS AND METHODS
|
|
TWI468188B
(zh)
|
2008-01-30 |
2015-01-11 |
Univ Tokushima |
Anti-cancer effect enhancers consisting of oxaliplatin liposomal preparations and anticancer agents comprising the formulation
|
|
FR2930264B1
(fr)
|
2008-04-18 |
2013-02-22 |
Gervais Danone Sa |
Nouvelle souche de lactobacillus paracasei subsp. paracasei dotee de proprietes antimicrobiennes et immunomodulatrices.
|
|
WO2009149149A1
(en)
|
2008-06-04 |
2009-12-10 |
Trustees Of Dartmouth College |
Prevention or treatment of immune-relevant disease by modification of microfloral populations
|
|
EP2326671A4
(en)
|
2008-09-05 |
2012-10-03 |
Ca Nat Research Council |
LIPOPOLYOSIDIC VACCINES
|
|
US20100081956A1
(en)
|
2008-09-30 |
2010-04-01 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Method, composition, and system to control pH in pulmonary tissue of a subject
|
|
JP2012524910A
(ja)
|
2009-04-23 |
2012-10-18 |
カリフォルニア インスティチュート オブ テクノロジー |
免疫調節物質の同定方法及びシステム
|
|
US8580278B2
(en)
|
2009-06-03 |
2013-11-12 |
Trustees Of Dartmouth College |
Nutraceutical composition and methods for preventing or treating multiple sclerosis
|
|
US20100311686A1
(en)
|
2009-06-03 |
2010-12-09 |
Kasper Lloyd H |
Nutraceutical composition and methods for preventing or treating multiple sclerosis
|
|
HUE040658T2
(hu)
|
2010-04-07 |
2019-03-28 |
California Inst Of Techn |
Vivõanyag vegyület mukózus membránhoz juttatásához és kapcsolódó készítmények, eljárások és rendszerek
|
|
US20110287048A1
(en)
|
2010-05-20 |
2011-11-24 |
Round June L |
Antigen Specific Tregs and related compositions, methods and systems
|
|
WO2011153226A2
(en)
|
2010-06-01 |
2011-12-08 |
Moore Research Enterprises Llc |
Cellular constituents from bacteroides, compositions thereof, and therapeutic methods employing bacteroides or cellular constituents thereof
|
|
US20140030807A1
(en)
|
2010-07-20 |
2014-01-30 |
Trustees Of Dartmouth College |
Method for stimulating foxp3+ regulatory t cell expression of cd39
|
|
HUE038600T2
(hu)
|
2010-10-07 |
2018-10-29 |
California Inst Of Techn |
Probiotikus terápiák autizmushoz
|
|
US20130064859A1
(en)
|
2011-01-28 |
2013-03-14 |
Sarkis K. Mazmanian |
Combinatorial vitamin d and probiotic therapy for inflammatory bowel disease
|
|
EP2731617A4
(en)
|
2011-07-12 |
2015-07-01 |
Brigham & Womens Hospital |
LIPID-BASED PSA COMPOSITIONS, METHOD FOR THEIR INSULATION AND USE METHOD THEREFOR
|
|
WO2013019896A1
(en)
|
2011-08-01 |
2013-02-07 |
Symbiotix Biotherapies, Inc. |
Platform for identifying and/or characterizing immunomodulatory agents
|
|
WO2013036290A1
(en)
|
2011-09-09 |
2013-03-14 |
Yale University |
Compositions and methods for assessing and treating inflammatory diseases and disorders
|
|
EP2764090B1
(en)
|
2011-10-03 |
2017-12-13 |
California Institute of Technology |
Generation of psa-only producing mutant strain
|
|
US20140072534A1
(en)
|
2012-08-30 |
2014-03-13 |
California Institute Of Technology |
Novel therapy for multiple sclerosis using vitamin d and gut bacteria
|
|
WO2014182966A1
(en)
|
2013-05-10 |
2014-11-13 |
California Institute Of Technology |
Probiotic prevention and treatment of colon cancer
|
|
BR112016021692A2
(pt)
|
2014-03-25 |
2017-08-15 |
The Government Of The Us Secretary Of The Army |
Métodos de preparação de uma composição imunogênica e de aperfeiçoamento de potência imunoestimuladora de vacinas adsorvidas em sal de alumínio, composição imunogênica e uso de uma composição de l(mpla)
|
|
JP6918365B2
(ja)
|
2015-08-19 |
2021-08-11 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
脂質化ｐｓａ組成物および方法
|
|
US11491181B2
(en)
|
2016-07-15 |
2022-11-08 |
President And Fellows Of Harvard College |
Glycolipid compositions and methods of use
|